Our Migraine Drip Treatment contains:
Drip health, in conjunction with NKMax America clinical laboratory, offers a COVID-19 Antibody Test (serology) which is an immunochromatographic assay that measures SARS-CoV-2 specific IgG/IgM antibodies from an immune response to COVID-19 infection. The test detects the presence of IgG and IgM antibodies to SARS-CoV-2 and is for patients who are not actively ill and have not experienced any symptoms for the past 10 days. This test requires a blood sample.
We also offer a real-time reverse-transcription polymerase chain reaction (real-time RT-PCR) assay to detect viral RNA for COVID-19 diagnosis and to help limit the spread of infection. The test detects the presence of SARS-CoV-2, the virus responsible for COVID-19 disease, and is for patients who exhibit signs and symptoms of COVID-19 infection. This test requires an upper respiratory (swab) sample collected by our healthcare professionals.
Both the COVID-19 RT-PCR and Antibody Tests are authorized by the FDA under Emergency Use Authorizations (EUA).
The NKMax America clinical laboratory is both CLIA-certified and CAP-accredited and is authorized to perform clinical laboratory testing services in the United States. We follow the strictest quality control guidelines in the industry to ensure the accuracy of patient test results.
CAP Accreditation #7541687 CLIA Certification #05D2027259 California Department of Public Health #CDF00341215.